Cadence Bank Amgen Inc Transaction History

Cadence Bank

$1.45 Billion
Q3 2024

A detailed history of Cadence Bank transactions in Amgen Inc stock. As of the latest transaction made, Cadence Bank holds 5,503 shares of AMGN stock, worth $1.62 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,503

Previous 5,726 3.89%

Holding current value

$1.62 Million

Previous $1.79 Million 0.89%

% of portfolio

0.12%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $68,991 - $75,235	-223 Reduced 3.89%	5,503 $1.77 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $12,612 - $15,326	-48 Reduced 0.83%	5,726 $1.79 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $183,907 - $221,999	684 Added 13.44%	5,774 $1.64 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $100,490 - $113,364	-393 Reduced 7.17%	5,090 $1.47 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $7,215 - $8,958	-33 Reduced 0.6%	5,483 $1.47 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $274,694 - $324,820	1,282 Added 30.28%	5,516 $1.22 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $883,967 - $1.08 Million	-3,915 Reduced 48.04%	4,234 $1.02 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $77,412 - $98,361	-338 Reduced 3.98%	8,149 $2.14 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $812,096 - $915,896	3,618 Added 74.31%	8,487 $1.91 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $51,909 - $57,766	-225 Reduced 4.42%	4,869 $1.19 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $13,156 - $14,554	60 Added 1.19%	5,094 $1.23 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $33,326 - $39,045	157 Added 3.22%	5,034 $1.07 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $599,157 - $698,220	-2,700 Reduced 35.63%	4,877 $1.21 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $584,226 - $695,709	2,700 Added 55.36%	7,577 $1.74 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $14,079 - $15,657	-60 Reduced 1.22%	4,877 $1.24 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $21,759 - $26,701	110 Added 2.28%	4,937 $1.16 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $12,210 - $16,193	-67 Reduced 1.37%	4,827 $979,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $25,354 - $32,588	134 Added 2.82%	4,894 $1.18 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $10,835 - $12,701	-65 Reduced 1.35%	4,760 $877,000
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $178 - $208	1 Added 0.02%	4,825 $939,000
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $15,008 - $16,920	-81 Reduced 1.65%	4,824 $1 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $10,793 - $12,123	65 Added 1.34%	4,905 $905,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $816,943 - $912,775	4,840	4,840 $0

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account